2014

This article describes the initiative and actions related to establishing a Digital Health Consortium (DHC) at the University of Colorado Denver. The consortium is a part of the Center for Information Technology Innovation (CITI) in the Business School.  The objective is to augment existing information systems program offerings in health information technology with the support of industry affiliates and other partners of the university.  The CITI-DHC is an industry-academia led initiative with a mission to accelerate digital health transformation through education, research, and service. We illustrate the vision and plan for the consortium, that will be fulfilled with academic and industry stakeholders, and who will be engaged with the platform to support digital health care innovations through collaborations. 

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Practical and legal preparation for young companies seeking technology transfer
Go to paperABSTRACT: This paper looks at the basic law of intellectual pr…

I will be discussing the 2014 issue of Scientific American Worldview at 12:45 in Room 3 at BIO2014 along with Mike

I will be signing copies of my textbook, Building Biotechnology from 3pm-4:30pm in Lobby D at BIO2014. Feel free to

I am seeking input on a new project which helps you identify top-performing patent attorneys. PatentStat.com uses cutting-edge research on patent

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology

Maryland and Virginia unite at 2007 Mid-Atlantic Bio Conference

Go to paper

ABSTRACT:   

The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.

Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:

• Management
• Policy
• Finance
• Law
• Regulation
• Bioethics

For more information, see the Journal of Commercial Biotechnology website